David H N, Abraini J H
UMR CNRS 6551, Centre Cyceron, BP5229, Université de Caen, Boulevard H. Becquerel, 14074 Caen cedex, France.
Neuropharmacology. 2001 Sep;41(4):454-63. doi: 10.1016/s0028-3908(01)00082-x.
There is strong evidence for the existence of functional interactions between metabotropic glutamate receptors and dopamine transmission in the nucleus accumbens. In the present study, we investigated the interactions between group II mGlu receptors and D1-like- and D2-like receptors in the rat nucleus accumbens. Administration of the selective group II metabotropic glutamate receptor agonist APDC, which had no effect when injected alone, potentiated the locomotor response produced by the selective D1-like receptor agonist SKF 38393 but had no effect on those induced by the selective D2-like receptor agonist quinpirole (also known as LY 171555)--a compound believed to act only at D2-like presynaptic receptors when injected alone--or co-administration of SKF 38393+quinpirole--a pharmacological condition thought to stimulate both D1-like receptors and presynaptic and postsynaptic D2-like receptors. In contrast, the selective group II mGlu receptor antagonist LY 341495, which induced an increase in basal locomotor activity, showed no effect on the SKF 38393-induced locomotor response, but abolished that produced by quinpirole or SKF 38393+quinpirole. The present findings demonstrate that stimulation of group II mGlu receptors has a cooperative and potentiating action on the locomotor response induced by D1-like receptor activation, whereas blockade of group II mGlu receptors has an antagonist action on the locomotor responses induced by activation of D2-like receptors. Although these data are consistent from a pharmacological point of view, as the effects of the group II mGlu receptor antagonist LY 341495 were blocked by the group II mGlu receptor agonist APDC and conversely, the subtle neurochemical crosstalks underlying such a differential effect of group II mGlu receptors on D1-like- and D2-like DA receptors remain to be elucidated.
有充分证据表明伏隔核中代谢型谷氨酸受体与多巴胺传递之间存在功能性相互作用。在本研究中,我们调查了大鼠伏隔核中II组代谢型谷氨酸受体与D1样和D2样受体之间的相互作用。单独注射时无作用的选择性II组代谢型谷氨酸受体激动剂APDC,增强了选择性D1样受体激动剂SKF 38393产生的运动反应,但对选择性D2样受体激动剂喹吡罗(也称为LY 171555)诱导的运动反应无影响——单独注射时该化合物被认为仅作用于D2样突触前受体——或SKF 38393与喹吡罗联合给药时诱导的运动反应无影响——这种药理学情况被认为可同时刺激D1样受体以及突触前和突触后D2样受体。相反,诱导基础运动活动增加的选择性II组代谢型谷氨酸受体拮抗剂LY 341495,对SKF 38393诱导的运动反应无影响,但消除了喹吡罗或SKF 38393与喹吡罗联合给药所产生的运动反应。本研究结果表明,刺激II组代谢型谷氨酸受体对D1样受体激活诱导的运动反应具有协同增强作用,而阻断II组代谢型谷氨酸受体对D2样受体激活诱导的运动反应具有拮抗作用。尽管从药理学角度来看这些数据是一致的,因为II组代谢型谷氨酸受体拮抗剂LY 341495的作用被II组代谢型谷氨酸受体激动剂APDC阻断,反之亦然,但II组代谢型谷氨酸受体对D1样和D2样多巴胺受体产生这种差异效应背后的微妙神经化学串扰仍有待阐明。